SCHEMBL1280452

SCHEMBL1280452

CC1COC(Cn2cncn2)(c2ccc(Oc3cc(Cl)ccc3F)cc2)O1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 17/20 0.49
THRB P10828 1/20 0.49
HSP90AA1 P07900 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
LMNA P02545 2/20 0.43
FYN P06241 2/20 0.43
CYP51A1 Q16850 2/20 0.43
NR1I2 O75469 1/20 0.43
PGR P06401 1/20 0.43
CHRM2 P08172 1/20 0.43
CHRM4 P08173 1/20 0.43
CHRM5 P08912 1/20 0.43
ADRA2A P08913 1/20 0.43
CHRM1 P11229 1/20 0.43
TSHR P16473 1/20 0.43
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43
CHRM3 P20309 1/20 0.43
DRD1 P21728 1/20 0.43
TBXA2R P21731 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1279403 0.94 CYP3A4 (0.49) CYP3A4THRBHSP90AA1NPSR1LMNA
SCHEMBL1279489 0.92 HSP90AA1 (0.47) CYP3A4THRBHSP90AA1NPSR1LMNA
SCHEMBL1279774 0.91 CYP3A4 (0.47) CYP3A4THRBHSP90AA1NPSR1LMNA
SCHEMBL1279771 0.90 CYP3A4 (0.62) CYP3A4THRBHSP90AA1NPSR1LMNA
SCHEMBL1279834 0.88 CYP3A4 (0.64) CYP3A4THRBHSP90AA1NPSR1LMNA
SCHEMBL1280246 0.88 CYP3A4 (0.52) CYP3A4THRBHSP90AA1NPSR1LMNA
SCHEMBL29110186 0.87 CYP3A4 (0.60) CYP3A4THRBHSP90AA1NPSR1LMNA
SCHEMBL1279391 0.87 CYP3A4 (0.55) CYP3A4THRBHSP90AA1NPSR1LMNA
SCHEMBL1279334 0.86 HSP90AA1 (0.47) CYP3A4THRBHSP90AA1NPSR1LMNA
SCHEMBL11545641 0.86 HSP90AA1 (0.59) CYP3A4THRBHSP90AA1NPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2443109-A1 TRIAZOLE COMPOUNDS CARRYING A SULFUR SUBSTITUENT BASF SE (DE) 2012-04-25 EP disclosed
US-20120088663-A1 Triazole Compounds Carrying a Sulfur Substituent BASF SE (DE) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088663-A1 Triazole Compounds Carrying a Sulfur Substituent TST, STS, SQOR CYP3A4 39/4885THRB 2274/4885HSP90AA1 3133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.